The relevant information included in this section is exactly as published on the website of the National Securities Market Commission (CNMV)

Filter results
Date Title Content PDF
9/07/2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate
2/07/2020 Liquidity contracts and specialists Liquidity contract: transactions conducted in the second quarter of 2020
13/05/2020 On business and financial situation ROVI releases the presentation related to the first quarter 2020 financial results
13/05/2020 Interim Management Report The company releases the press release related to the 2020 first quarter financial results
13/05/2020 Announcement of general shareholders’ meeting ROVI releases the information related to its 2020 General Shareholders Meeting
2/04/2020 On business and financial situation ROVI informs on the impact of Covid‑19 on the company’s activities
2/04/2020 Liquidity contracts and specialists Liquidity contract: transactions conducted in the first quarter of 2020
26/02/2020 Information on P&L ROVI releases the full year 2019 results presentation
26/02/2020 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2019 annual report regarding remuneration of the members of the Board of Directors 
26/02/2020 Information on P&L ROVI releases the press release related to the full year 2019 financial results

Pages